Cognitive Behavioral Therapy as an Intervention to Prevent Weight Rebound post Semaglutide Discontinuatio
Not Applicable
- Conditions
- Obesity
- Registration Number
- JPRN-UMIN000053018
- Lead Sponsor
- kansai medical university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who fall under any of the following will not be included in this study. 1) Patients with severe hepatic or renal dysfunction 2) Pregnant and lactating women 3) Patients with malignant tumor 4) Patients with severe heart failure/arrhythmia 5) Patients with secondary obesity due to endocrine (hormone) or other drugs, etc. 6) Patients with a history of hypersensitivity to semaglutide 7) Patients with diabetic ketoacidosis, diabetic coma or precoma, type 1 diabetes 8) Severe infections in patients with type 2 diabetes, conditions requiring emergency surgery, etc. 9) Other patients deemed unsuitable as research subjects by the research director
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Weight change rate from discontinuation of semaglutide to 24 weeks after discontinuation
- Secondary Outcome Measures
Name Time Method